Articles in 2015

Filter By:

Article Type
Year
  • Bioinformatic and biochemical analyses define a conserved domain present in the biosynthetic clusters for ribosomally synthesized and post-translationally modified peptides (RiPPs) that recognizes the leader peptide and thus controls downstream processing.

    • Brandon J Burkhart
    • Graham A Hudson
    • Douglas A Mitchell
    Article
  • A fusion protein containing P450 and aldo-keto reductase domains is shown to catalyze reticuline isomerization, the critical branch point between the noscapine and morphine biosynthetic pathways. This discovery completes the enzymatic route to morphine and related compounds.

    • Scott C Farrow
    • Jillian M Hagel
    • Peter J Facchini
    Article
  • Structural, spectroscopic and kinetic analyses suggest that class II benzoyl-CoA reductases from anaerobic bacteria use an unusual tungsten cofactor and a conserved histidine to perform a reduction akin to the widely used Birch reduction in organic chemistry.

    • Tobias Weinert
    • Simona G Huwiler
    • Matthias Boll
    Article
  • Pseudouridine (ψ) is a C-linked uracil modification originally discovered in tRNA. MS analysis and CeU-Seq, a method that permits chemical tagging, pulldown and sequencing of ψ residues, reveal that these modifications are more abundant in the mammalian transcriptome than previously thought.

    • Xiaoyu Li
    • Ping Zhu
    • Chengqi Yi
    Article
  • Carotenoid biosynthesis requires isomerization of the central double bond. Informatic, spectroscopic and functional characterization of Z-ISO, a protein involved in the process, demonstrates that it is a standalone enzyme with unusual heme-dependent chemistry.

    • Jesús Beltrán
    • Brian Kloss
    • Eleanore T Wurtzel
    Article
  • The use of a high-affinity VHL ligand allows the development of chimeric molecules that promote the association of ERRα or RIPK2 with the VHL E3 ubiquitin ligase complex, resulting in protein degradation.

    • Daniel P Bondeson
    • Alina Mares
    • Craig M Crews
    Article
  • An amphotericin antifungal that is less toxic to human cells due to its increased capacity for binding the fungal ergosterol over the human cholesterol can still evade resistance mechanisms, challenging the resistance-toxicity yin-yang of antimicrobials.

    • Stephen A Davis
    • Benjamin M Vincent
    • Martin D Burke
    Article
  • A newly engineered phosphoserine synthetase/tRNA pair allows quantitative insertion of phosphoserine or, when coupled with metabolic rewiring, a non-hydrolyzable analog into protein sequences, leading to high yields of modified constructs for functional analysis.

    • Daniel T Rogerson
    • Amit Sachdeva
    • Jason W Chin
    Article
  • A high-throughput screen identified a small molecule that promoted inclusion of SMN2 exon 7, increased SMN2 protein levels and extended survival in a SMA mouse model through stabilization of the interaction between SMN2 pre-mRNA and U1 snRNP complex.

    • James Palacino
    • Susanne E Swalley
    • Rajeev Sivasankaran
    Article
  • NO2 has been viewed primarily as a reservoir for NO and NO-modified species, activated by acids or metal catalysis. Isotopic labeling of NO and NO2 modifications in vitro and in vivo now demonstrates that NO2 also participates directly in these reactions through a symmetric N2O3 intermediate.

    • Dario A Vitturi
    • Lucia Minarrieta
    • Francisco J Schopfer
    Article
  • The biosynthesis of benzylisoquinoline alkaloids such as morphine requires tyrosine oxidases, which are prone to overoxidation. A colorimetric readout that co-opts betaxanthin enzymes now enables discovery of an improved oxidase that, with other enzymes, makes reticuline in yeast.

    • William C DeLoache
    • Zachary N Russ
    • John E Dueber
    Article
  • Topoisomerase inhibitors are genome-targeting drugs that induce DNA double-strand breaks or evict histones at sites of action. Genomic mapping of their target sites by ChIP-Seq and FAIRE-Seq and integration with ENCODE data identifies the target specificities of topoisomerase inhibitors and suggests ways to optimize their therapeutic properties.

    • Baoxu Pang
    • Johann de Jong
    • Jacques Neefjes
    Article